Author + information
- Received September 8, 1992
- Revision received December 7, 1992
- Accepted March 10, 1993
- Published online September 1, 1993.
- Gordon W. Moe, MSc, MD, FACC∗,1,
- Etienne A. Grima, MSc,
- Norman L.M. Wong, PhD,
- Robert J. Howard, MD, FACC and
- Paul W. Armstrong, MD, FACC
- ↵∗Address for correspondence: Gordon W. Moe, MD, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario, Canada
Objectives. The objectives of this study were 1) to define in an experimental model of heart failure the time course of changes in plasma brain natriuretic peptide concentrations during the development of and recovery from heart failure, and 2) to relate these changes to changes in atrial natriuretic peptide concentration and hemodynamic status.
Background. Brain natriuretic peptide is a circulating peptide with homology to atrial natriuretic peptide. However, unlike the latter, its changes during heart failure and its relation to cardiac filling pressures have not been studied.
Methods. Eight male mongrel dogs underwent right ventricular pacing at 250 beats/min for 3 weeks until heart failure occurred and were followed up during recovery for 4 weeks after cessation of pacing.
Results. Heart failure was characterized by an increase in both left ventricular end-diastolic pressure (6.6 ± 4.1 mm Hg at the control measurements to 35.1 ± 5.9 mm Hg at 3 weeks, p < 0.01) and right atrial pressure (6.7 ± 1.1 to 11.4 ± 2.1 mm Hg, p < 0.01). Recovery was accompanied by a return of cardiac filling pressures to control level. The time course of change of arterial plasma brain natriuretic peptide concentration was similar to that of atrial natriuretic peptide. Plasma concentrations of both peptides increased after 1 week of pacing (16 ± 4 pg/ml at the control measurement to 59 ± 20 pg/ml at 1 week, p < 0.001 for brain natriuretic peptide and 84 ± 55 to 856 ± 295 pg/ml, p < 0.001 for atrial natriuretic peptide). The level of both peptides then stayed level with no further increase at 3 weeks and returned to the control value by 4 weeks of recovery. There was an excellent correlation between plasma concentrations of the two peptides (r = 0.86, p < 0.001) and between the two peptides and cardiac filling pressures. However, compared with atrial natriuretic peptide, plasma brain natriuretic peptide concentration had a smaller percent increase during evolving heart failure and a slower rate of decline at recovery.
Conclusions. Brain and atrial natriuretic peptide constitute a dual natriuretic system and are both responsive to changes in cardiac filling pressures in heart failure. However, brain natriuretic peptide appears to be less responsive than atrial natriuretic peptide.
↵1 Dr. Moe is a scholar of the Heart and Stroke Foundation of Ontario.
☆ This study was supported by grants-in-aid from the Heart and Stroke Foundation of Ontario, Toronto and from the British Columbia Heart Foundation, Vancouver.
- Received September 8, 1992.
- Revision received December 7, 1992.
- Accepted March 10, 1993.